A hair-and-nail supplement can be relevant to a sermorelin follow-up appointment even if you do not think of it as medicine. Biotin, also called vitamin B7, can interfere with certain laboratory methods and produce misleading results. That is a testing problem, not proof that it blocks sermorelin or changes every hormone level.
Tell the ordering clinician and laboratory what you take before the blood draw, including the product label, amount, and most recent use. Ask for instructions specific to the ordered tests. Do not stop a prescribed treatment or apply a universal supplement break from an online comment.
Disclose biotin before testing. The laboratory method and clinical context determine whether interference needs to be addressed.
A changed test signal is not necessarily a changed hormone
NIH explains that biotin can affect tests using certain laboratory technologies, including some hormone measurements. Depending on the method, results can appear higher or lower than they should. FDA separately warns about affected tests used to measure troponin, a marker involved in evaluating heart injury.
That does not mean every test at every laboratory is affected. It also does not establish a direct interaction between biotin and sermorelin. The distinction matters because a misleading result could prompt the wrong interpretation even when the underlying condition has not changed in the way the report suggests.
Check the full supplement list, not just one bottle
Bring or photograph the ingredient panels for hair products, multivitamins, and other supplements. Record the serving size, the amount you actually take, and when you last took it. A front-label description such as beauty support does not give the laboratory the same information as the ingredient panel.
MedlinePlus recommends reporting medicines, vitamins, and supplements when preparing for laboratory testing. The drug-interaction guide offers a broader medication-review checklist. Include products recommended by another clinician so the ordering team can coordinate advice rather than asking you to make conflicting changes alone.
Ask about the specific tests on your order
If the panel includes thyroid testing or other hormones, ask whether the laboratory method is susceptible to biotin interference. For IGF-1 or any other marker, do not assume a problem merely because it is a hormone-related test. The laboratory can assess the actual assay it uses.
Our IGF-1 guide covers clinical interpretation, while the thyroid guide explains why existing thyroid care belongs in the discussion. Testing methods, reference ranges, symptoms, and treatment history all help determine what a result means.
Get preparation instructions before the appointment
Ask the clinician or lab whether any change to biotin use is needed and, if so, exactly when to make it. This guide does not provide a fixed number of hours or days because a generic rule cannot account for every supplement exposure and assay.
Check fasting and medicine instructions separately. A request to fast does not answer the biotin question, and a supplement instruction does not authorize changing sermorelin or another prescription. If you did not follow the preparation instructions, tell the lab before the sample is collected so the team can decide what to do.
Discuss an unexpected result before changing treatment
If a report looks inconsistent with your symptoms or previous results, tell the clinician about supplement use around the collection time. NIH notes that clinicians should consider possible biotin interference when results do not fit the clinical picture. The lab may help determine whether another method or repeat sample is useful.
Do not assume every surprising result is an error. A real medical change still needs assessment. Keep the original report, collection date, and supplement details available, and let the treating clinician decide whether a treatment change or further evaluation is appropriate.
Do not delay emergency care or add biotin without a reason
FDA's concern about falsely low troponin results makes supplement disclosure important in urgent care too. If you have symptoms of a medical emergency, seek help immediately and tell the team what you take. Do not wait for a supplement to leave your system before seeking assessment.
Biotin is often marketed for hair and nails, but NIH describes limited evidence for cosmetic benefits in otherwise healthy people. The hair-loss guide emphasizes identifying the cause of shedding. Adding a supplement is not a substitute for that evaluation and can complicate the interpretation of later tests.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- NIH ODS: Biotin fact sheetGovernment or medical organization guidance · Supplement evidence and assay-dependent laboratory interference.
- FDA: Biotin interference with troponin testsGovernment or medical organization guidance · Some assays are affected; not a universal sermorelin interaction or stop interval.
- MedlinePlus: Preparing for a laboratory testGovernment or medical organization guidance · Follow the ordering clinician and laboratory instructions; no self-directed medicine changes.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.